Search Results

Feb 24, 2026, 02:00 ET etherna's intratumoral mRNA/LNP platform advances to clinical testing in nonmelanoma skin cancer led by Almirall

sciences industry, supporting projects from early research over development to GMP manufacturing. The company is headquartered in Niel, Belgium, with R&D facilities in Ghent and commercial operations in the U.S. and Asia.www.etherna.bio Logo

More news about: etherna

Feb 24, 2026, 01:44 ET Fractal Launches PiEvolve, an Evolutionary Agentic Engine for Autonomous Machine Learning and Scientific Discovery

Kalaido.ai, and the open-source reasoning model Fathom-R1-14B and tool-based reasoning model Fathom-DeepResearch.Fractal

More news about: Fractal Analytics Limited

Feb 24, 2026, 01:33 ET Fractal Launches PiEvolve, an Evolutionary Agentic Engine for Autonomous Machine Learning and Scientific Discovery

Kalaido.ai, and the open-source reasoning model Fathom-R1-14B and tool-based reasoning model Fathom-DeepResearch.Fractal

More news about: Fractal Analytics Limited

Feb 24, 2026, 01:25 ET Fractal Launches PiEvolve, an Evolutionary Agentic Engine for Autonomous Machine Learning and Scientific Discovery

Kalaido.ai, and the open-source reasoning model Fathom-R1-14B and tool-based reasoning model Fathom-DeepResearch.Fractal

More news about: Fractal Analytics Limited

Feb 23, 2026, 21:58 ET Blokees Exhibits a Diverse Product Portfolio at Toy Fair New York 2026

fairs worldwide, demonstrating its product innovation capabilities and growing global influence. Looking ahead, Blokees will continue to leverage its R&D strength and innovative product system to deliver more product offerings and an elevated experience to consumers worldwide.

More news about: Blokees

Feb 23, 2026, 20:25 ET TCL congratulates Global Brand Ambassador Eileen Gu on historic performance at Milano Cortina 2026, inspiring greatness among audiences worldwide

devices, display technologies, and clean energy—that enhance customer experiences through TCL Industries and TCL Technology.As of now, with 47 R&D centers and 39 manufacturing bases globally, TCL operates in over 160 countries and regions, cementing its position as a globally competitive smart

More news about: TCL

Feb 23, 2026, 20:00 ET Panasonic Automotive Systems secures industry-wide endorsement for its initiative to standardize VirtIO device virtualization technology

Panasonic Automotive Systems in advancing an open and scalable automotive software ecosystem." – Moonsoo Kim, Head of System Semiconductor Center, R&D division, Telechips Inc.Xen Project"The Xen Project believes that VirtIO is a key enabling technology for

More news about: Panasonic Corporation of North America

Feb 23, 2026, 17:31 ET Acromegaly Market Poised for Significant Expansion During the Forecast Period (2026-2036) as New Treatment Options Emerge | DelveInsight

The dynamics of the acromegaly market are anticipated to change due to extensive R&D, the entry of novel therapies such as Debio 4126 (Debiopharm International SA), ALXN2420 (AstraZeneca), MAR002 (Marea Therapeutics), Paltusotine (Crinetics Pharmaceuticals), CAM2029 (Camurus AB), and others,

More news about: DelveInsight Business Research, LLP

Feb 23, 2026, 17:13 ET FIBRA Prologis Anuncia sus Resultados Financieros del Cuarto Trimestre y Año Completo de 2025

https://mma.prnewswire.com/media/528012/FIBRA_Prologis_R1_Logo.jpg FUENTE FIBRA Prologis

More news about: FIBRA Prologis

Feb 23, 2026, 17:06 ET FIBRA Prologis Anuncia sus Resultados Financieros del Cuarto Trimestre y Año Completo de 2025

https://mma.prnewswire.com/media/528012/FIBRA_Prologis_R1_Logo.jpg

More news about: FIBRA Prologis

Feb 23, 2026, 17:00 ET Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer

Astellas"Astellas is proud to have helped 1.5 million patients with prostate cancer, and we are dedicated to expanding our impact as part of our R&D strategy. Our deep expertise in this disease area, combined with a growing immuno-oncology (IO) pipeline of biologics, including T-cell engagers, uniquely

More news about: Astellas Pharma Inc.

Feb 23, 2026, 16:05 ET BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results

company also includes a Non-GAAP adjustment for the estimated tax impact of the reconciling items. Non-GAAP R&D expenses and Non-GAAP SG&A expenses are defined by the company as GAAP R&D expenses and GAAP SG&A expenses, respectively, excluding stock-based compensation expense and, in certain

More news about: BioMarin Pharmaceutical Inc.

Feb 23, 2026, 15:33 ET CoreWeave, Inc. (CRWV) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Advertising in some jurisdictions under the applicable law and ethical rules.Contact Us: The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz, Telephone: 310-914-5007Email: [email protected]

More news about: The Law Offices of Frank R. Cruz, Los Angeles

Feb 23, 2026, 14:49 ET /C O R R E C T I O N -- Oncura Health/

More news about: Oncura Health

Feb 23, 2026, 14:13 ET AUI Acquires Quack AI, Developer of AI Customer Service Agent Technology

which developed a specialized technology for operating AI agents for customer service. The agreement is expected to double the size of AUI's Israeli R&D team in Tel Aviv.Quack AI was founded in 2023 by Nadav Kemper, CEO, and Aviram Roisman, CTO, and currently employs 15 people. The company participated

More news about: Augmented Intelligence (AUI) Inc.

Feb 23, 2026, 14:03 ET Orthopedic Power Tools Market to Reach USD 2,275.91 Million by 2032 on Back of Robotics and Minimally Invasive Surgery Adoption - Credence Research Inc.

invest continuously in compliance and quality management.High Research and Development CostsContinuous innovation requires heavy R&D investment. Companies must develop lighter, more powerful, and more connected tools that work seamlessly with robotic systems and digital platforms.

More news about: Credence Research Inc.

Feb 23, 2026, 12:00 ET /C O R R E C T I O N -- Newell Brands/

More news about: Newell Brands